169 related articles for article (PubMed ID: 29198389)
1. Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease.
Huang P; Yu G; Kapp DS; Bian XF; Ma CS; Li HS; Chen JH; Liang YQ; Zhang Y; Qin SH; Xie YQ; Yang Y; Yin Y; Xing L; Li DW
Med Dosim; 2018 Autumn; 43(3):258-266. PubMed ID: 29198389
[TBL] [Abstract][Full Text] [Related]
2. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
4. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
[TBL] [Abstract][Full Text] [Related]
8. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
[TBL] [Abstract][Full Text] [Related]
9. A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.
Chen D; Wang R; Meng X; Liu T; Yan H; Feng R; Liu S; Jiang S; Xu X; Zhu K; Dou X
Radiat Oncol; 2014 Feb; 9():48. PubMed ID: 24502643
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description.
Cheng JC; Wu JK; Huang CM; Huang DY; Cheng SH; Lin YM; Jian JJ; Yang PS; Chuang VP; Huang AT
Radiother Oncol; 2002 Apr; 63(1):41-5. PubMed ID: 12065102
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric study of three-dimensional static and dynamic SBRT radiotherapy for hepatocellular carcinoma based on 4DCT image deformable registration.
Ma C; Duan J; Yu S; Ma C
J Appl Clin Med Phys; 2020 Feb; 21(2):60-66. PubMed ID: 31889422
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.
Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412
[TBL] [Abstract][Full Text] [Related]
14. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
15. Partial volume tolerance of the liver to radiation.
Dawson LA; Ten Haken RK
Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
[TBL] [Abstract][Full Text] [Related]
16. Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05).
Bae SH; Park HC; Yoon WS; Yoon SM; Jung IH; Lee IJ; Kim JW; Seong J; Kim TH; Nam TK; Choi Y; Lee SY; Jang HS; Lee DS; Kim JH
Cancer Res Treat; 2019 Oct; 51(4):1589-1599. PubMed ID: 30971065
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced Liver Injury after 3D-conformal Radiotherapy for Hepatocellular Carcinoma: Quantitative Assessment Using Gd-EOB-DTPA-enhanced MRI.
Fukugawa Y; Namimoto T; Toya R; Saito T; Yuki H; Matsuyama T; Ikeda O; Yamashita Y; Oya N
Acta Med Okayama; 2017 Feb; 71(1):25-29. PubMed ID: 28238007
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma.
Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS
Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122
[TBL] [Abstract][Full Text] [Related]
19. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
[TBL] [Abstract][Full Text] [Related]
20. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.
Yoon HI; Koom WS; Lee IJ; Jeong K; Chung Y; Kim JK; Lee KS; Han KH; Seong J
Liver Int; 2012 Aug; 32(7):1165-71. PubMed ID: 22435801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
